Insider Transactions in Q1 2021 at Repligen Corp (RGEN)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 16
2021
|
Christine Gebski |
SELL
Open market or private sale
|
Direct |
1,400
-3.63%
|
$274,400
$196.88 P/Share
|
Mar 12
2021
|
Thomas F Ryan Jr Director |
SELL
Bona fide gift
|
Direct |
170
-11.61%
|
-
|
Mar 12
2021
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
9,102
-0.6%
|
$1,738,482
$191.11 P/Share
|
Mar 10
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
8,000
-8.44%
|
$1,528,000
$191.18 P/Share
|
Mar 10
2021
|
Ralf Kuriyel Senior VP, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+7.43%
|
$336,000
$42.15 P/Share
|
Mar 04
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
2,075
-1.56%
|
$398,400
$192.81 P/Share
|
Mar 04
2021
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,545
-1.47%
|
$684,185
$193.15 P/Share
|
Mar 04
2021
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
21,900
-1.04%
|
$4,182,900
$191.48 P/Share
|
Mar 03
2021
|
Thomas F Ryan Jr Director |
SELL
Open market or private sale
|
Direct |
1,000
-40.58%
|
$205,000
$205.0 P/Share
|
Mar 03
2021
|
Thomas F Ryan Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+28.87%
|
$26,000
$26.12 P/Share
|
Feb 24
2021
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
10,437
+4.11%
|
-
|
Feb 24
2021
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
1,686
+5.81%
|
-
|
Feb 24
2021
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,410
+6.29%
|
-
|
Jan 25
2021
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+10.67%
|
$132,000
$33.87 P/Share
|
Jan 04
2021
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,957
-1.77%
|
$759,744
$192.4 P/Share
|